Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)

1. González-Santiago, S.
2. Saura, C.
3. Ciruelos, E.
4. Alonso, J.L.
5. de la Morena, P.
6. Santisteban Eslava, M.
7. Gallegos Sancho, M.I.
8. de Luna, A.
9. Dalmau, E.
10. Servitja, S.
11. Ruiz Borrego, M.
12. Chacón, J.I.